
New Generic Drug House Private Limited
Manufactures and sells bulk drugs, medicines, and formulations for medical and industrial use.
Manufactures and sells bulk drugs, medicines, and formulations for medical and industrial use.
New Generic Drug House Private Limited (NGDHPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 May 1983 and has a history of 41 years and ten months. Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 9.66 M.
The company has closed loans amounting to ₹6.85 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dhirajlal Patel and Jasumati Vyas serve as directors at the Company.
Valsad, Gujarat, India
+91-XXXXXXXXXX
U24230GJ1983PTC006156
006156
Private Limited Indian Non-Government Company
05 May 1983
29 Sep 2018
31 Mar 2018
Unlisted
Roc Ahmedabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dhirajlal Patel ![]() | Director | 09-Jun-2010 | Current |
Jasumati Vyas ![]() | Additional Director | 26-Feb-2019 | Current |
New Generic Drug House Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 50% decrease. The company also saw a substantial improvement in profitability, with a 97.04% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, New Generic Drug House had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹0
₹6.85 Cr
Date | Lender | Amount | Status |
---|---|---|---|
29 Mar 2004 | Jankalyan Sehkari Bank Ltd | ₹3.50 M | Satisfied |
23 Jul 2003 | Jankalyan Sehkari Bank Ltd | ₹7.50 M | Satisfied |
16 Jan 2002 | Jankalyan Sehkari Bank Ltd | ₹2.00 Cr | Satisfied |
28 Jan 2000 | Jankalyan Sehkari Bank Ltd | ₹1.50 Cr | Satisfied |
01 Sep 1998 | Jankalyan Sahakari Bank Limited | ₹2.50 M | Satisfied |
Unlock and access historical data on people associated with New Generic Drug House, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of New Generic Drug House, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Generic Drug House's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jasumati Pramodrai Vyas was appointed as a Additional Director was appointed as a Additional Director on 26 Feb 2019 & has been associated with this company since 6 years 21 days .
New Generic Drug House Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
New Generic Drug House Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ahmedabad.
A charge registered on 29 Mar 2004 via Charge ID 90110714 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010.
A charge registered on 23 Jul 2003 via Charge ID 90110594 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010.
A charge registered on 16 Jan 2002 via Charge ID 90110393 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010.
New Generic Drug House Private Limited was incorporated on 05 May 1983.
The authorized share capital of New Generic Drug House Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 9.66 M.
Currently 2 directors are associated with New Generic Drug House Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of New Generic Drug House Private Limited is 211 213 Gidc Industrial Estate, Village- Sarigam India, Valsad, Gujarat, 396155.
The corporate identification number (CIN) of New Generic Drug House Private Limited is U24230GJ1983PTC006156 and the company number is 006156 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2018, the revenue trend for New Generic Drug House Private Limited has fallen by -50.00%.
The financial reports for the fiscal year 2018 indicates that The net worth of New Generic Drug House Private Limited has experienced an downturn of -0.00%.
The most recent Balance Sheet for New Generic Drug House Private Limited was filed with the ROC on 31 Mar 2018.
Search company & director profiles for free and gain access to critical business data.
AV
MT